tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
Israel Market

Xtl Bio (XTLB) Income Statement

Compare
0 Followers

Xtl Bio Income Statement

Last quarter (Q4 2024), Xtl Bio's total revenue was $289.00K, an increase of Infinity% from the same quarter last year. In Q4, Xtl Bio's net income was $-255.00K. See Xtl Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 451.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.17M$ 765.00K$ 880.00K$ 1.03M$ 948.00K
Depreciation and Amortization
$ 199.00K$ 1.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -930.00K$ -764.00K$ -879.00K$ -1.03M$ -947.00K
Operating Income
$ -2.17M$ -765.00K$ -880.00K$ -1.03M$ -948.00K
Other Income/Expenses
$ 1.01M$ -1.02M$ -468.00K$ 1.47M$ -2.01M
Pretax Income
$ -1.16M$ -1.78M$ -1.35M$ 435.00K$ -2.95M
Net Income
$ -1.03M$ -1.78K$ -1.35M$ 435.00K$ -782.00K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -0.01
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -0.01
Weighted Average Shares Outstanding
673.04M 544.95M 544.91M 615.55M 514.21M
Weighted Average Shares Outstanding (Diluted)
704.16M 544.91M 544.91M 615.55M 514.21M
Currency in USD

Xtl Bio Earnings and Revenue History